Approval spans early and levodopa-treated disease; a 6-week titration and CYP3A interactions put pharmacists at the center of starting therapy.
|Articles|May 11, 2022
Daily OTC Pearl: DenTek Instant Pain Relief
Author(s)Saro Arakelians, PharmD
DenTek Instant Pain Relief helps soothe pain from toothaches, sore gums, and mouth sores.
Advertisement
OTC/Lifestyle Pearl of the Day: DenTek Instant Pain Relief
Indication: DenTek Instant Pain Relief helps soothe pain from toothaches, sore gums, and mouth sores.
Insight:
- Benzocaine 20%
- Sanitary applicator target areas with precision.
- Includes one bottle of Benzocaine (20%), 50 disposable applicators, applicator handle, and carrying case.
Source:
Advertisement
Related to this article
In a Pharmacy Times interview, study coauthor William J. Peppard, PharmD, discusses the association between suzetrigine and fewer opioid refills after knee replacement, the limits of the evidence, and the access barriers pharmacists can help patients navigate.
Novo's topline phase 3 data show 12.4% weight loss with CagriSema 1.0 mg/1.0 mg in type 2 diabetes and 21.0% in adults with overweight or obesity.
Researchers found substantial overlap in autonomic symptoms, orthostatic tachycardia, and functional impairment between long COVID and POTS.
A review of 69 studies finds influenza vaccines continue to reduce hospitalization and death, with no new safety concerns.
Isatuximab plus Iberdomide maintenance helps MRD-positive myeloma patients turn MRD-negative after transplant, with manageable safety.
Insulin efsitora alfa-gobe (Onswik; Eli Lilly and Company) is designed to deliver steady basal insulin levels over a full 7-day duration.
Vallerie McLaughlin, MD, explains why the ERS update strongly recommends sotatercept for patients with pulmonary arterial hypertension (PAH) who don't reach low-risk status on initial therapy.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Tavapadon, First D1/D5 Agonist for Parkinson Disease
2
Ramantamig's 93.6% ORR and Outpatient CRS Control
3
Engineered Stem Cell Therapy Reverses New-Onset T1D in Mice by Reprogramming T Cells
4
CagriSema Tops Tirzepatide 5 mg for Weight Loss in REIMAGINE 5
5